Date posted
Dec
22
In late December 2025, Congress completed action on the FY 2026 National Defense Authorization Act (NDAA)and with it, the...
Read PostNews
Stay up-to-date on the latest industry, member, & policy related news.
Share your News
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
Advocacy
Advocacy :
Federal Advocacy
Advocacy :
State Advocacy
Association Updates
Event
Event :
Industry Event
Event :
MichBio Advocacy Events
Event :
MichBio Networking Event
Event :
MichBio Signature Event
Event :
MichBio Webinar
Event :
Partner Event
Member Feature
News
News :
Industry News
News :
Member News
News :
MichBio News/Statement
News :
Michigan News
Date posted
Dec
22
Access to capital remains one of the most persistent challenges facing early-stage life sciences companies. On December 11, the U.S. House of...
Read Post
Date posted
Dec
22
Mergers and acquisitions (M&A) are a defining feature of the global life sciences industry. While often discussed in terms of market...
Read Post
Date posted
Dec
22
In October, MichBio was awarded a competitively selected Michigan Innovation Fund (MIF) grant to launch MI BioTalent Connect, a new statewide...
Read Post
Date posted
Dec
22
The U.S. Food and Drug Administration (FDA) has taken a noteworthy step toward modernizing how it collaborates with innovative technology...
Read Post
Date posted
Dec
22
In 2025, MichBio continued to advance its core mission: strengthening Michigan’s life sciences ecosystem by connecting people, shaping...
Read Post
Date posted
Dec
8
America stands at a pivotal moment in biotechnology and scientific innovation. The National Security Commission on Emerging Biotechnology...
Read Post
Date posted
Dec
8
On December 1, 2025, Washington and London announced an “agreement in principle” that does two big things at once: it shields...
Read Post
Date posted
Dec
8
The Advanced Research Projects Agency for Health (ARPA-H) – Health & Human Service (HHS)’s “high-risk,...
Read Post
Date posted
Dec
8
After the FDA’s Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) authority lapsed at the end of 2024, patient groups and drug...
Read Post
Date posted
Dec
8
A major bipartisan push to overhaul pharmacy benefit managers (PBMs) is back on the Senate agenda. On Dec. 4, Senate Finance Committee...
Read Post
Date posted
Dec
5
People are investing more than ever in supplements, treatments, and products that promise to slow the aging process. In fact, the global anti-aging...
Read Post